[EN] NOVEL INHIBITORS OF DIPEPTIDYL PEPTIDASE IV<br/>[FR] NOUVEAUX INHIBITEURS DE DIPEPTIDYL PEPTIDASE IV
申请人:GUILFORD PHARM INC
公开号:WO2004041795A1
公开(公告)日:2004-05-21
Novel inhibitors of dipeptidyl peptidase IV (DPP IV), pharmaceutical compositions comprising therapeutically effective amounts of novel inhibitors of DPP IV, and novel methods of treating medical conditions are provided. The novel inhibitors of DPP IV described herein are useful in the treatment of neurological disorders, diabetes, inflammatory disorders such as arthritis, obesity, osteoporosis, and of such other enumerated conditions as can be treated with inhibitors of DPP IV.
Enantioselective synthesis of 2,3-disubstituted piperidines from (S)-methylpyroglutamate
作者:Olivier Calvez、Angèle Chiaroni、Nicole Langlois
DOI:10.1016/s0040-4039(98)02190-x
日期:1998.12
N-methoxy-N-methylamide derived from (S)-methylpyroglutamate was prepared in good yield and allowed the addition of Grignard reagents. Erythro (2S)-1-benzyl-2-hydroxybenzyl pyrrolidine obtained by this way was converted into (2S,3R)-1-benzyl-3-hydroxy-2-phenylpiperidine and its chloro analog.